Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Impilo on the establishment of a continuation fund
Mandate

Vinge advises Impilo on the establishment of a continuation fund

November 15, 2024

Vinge has advised Impilo with regulatory advice on the establishment of Impilo Orphan Drugs, a so-called continuation fund. The continuation fund will have EUR 320m in commitments and will invest in Immedica, in which KKR recently became an owner alongside Impilo.

Impilo is a Nordic investment company specializing in investments within the pharmaceutical, medical technology, healthcare services and other health-related industries. Impilo holds a highly diversified portfolio of healthcare investments and manages approximately EUR 1 billion in capital, from leading Nordic and international investors.

Vinges team consisted of Nils Unckel, Anton Sjökvist and Viktoria Wnuk.

Related

Vinge advises InArea on entering into a SEK 450 million credit agreement with SEB

 InArea's new facilities agreement comprises a term loan and a revolving credit facility, replacing the company's existing facilities. The facilities agreement also includes an option to increase the lending framework through an incremental facility of up to SEK 200 million.
June 03, 2026

Vinge advises Axcel in connection with the investment in Sanviva

 Vinge has advised the Nordic private equity firm Axcel in connection with the establishment of Sanviva, a new European medical device distribution network.
June 03, 2026

Vinge advises Platzer on the acquisition of a logistics property in Sörred Logistics Park

 Vinge has advised Platzer on the acquisition of the property Sörred 8:15 in Sörred Logistics Park in Hisingen in Gothenburg. The acquisition is performed in accordance with the purchase option held by Platzer in the joint venture with Catena, which grants priority to acquire completed projects at market value. The purchase price is based on an underlying property value of SEK 570 million, less deferred tax. Closing is expected to take place on 1 July 2026.
June 02, 2026